Circulation. 1998;97:282-289
(Circulation. 1998;97:282-289.)
© 1998 American Heart Association, Inc.
Chronic Heart Failure in the United States
A Manifestation of Coronary Artery Disease
Mihai Gheorghiade, MD;
; Robert O. Bonow, MD
From the Division of Cardiology, Northwestern University Medical School,
Chicago, Ill.
Correspondence to Robert O. Bonow, MD, Division of Cardiology, Northwestern University Medical School, 250 E Superior, Wesley 524, Chicago, IL 60611.
Key Words: coronary disease endothelium heart failure ischemia
Despite significant
progress in the prevention and treatment of
cardiovascular disease in the United States in the past
two decades,1 national statistics indicate that
the incidence and prevalence of chronic heart failure have been
increasing steadily in recent years,2 especially
in the elderly.3 It is estimated that
4 to
5 million individuals living in the United States have chronic heart
failure, with 400 000 new cases occurring each
year.4 5 6 Chronic heart failure results in almost
1 million hospitalizations each year7 and is the
most common hospital discharge diagnosis in patients above the age of
65 years.8 The evaluation and care of patients
with heart failure, not taking into account lost wages and
productivity, cost our society in excess of $11 billion each
year.7 8 9
In the past two decades, considerable attention has been placed on left
ventricular (LV) dysfunction, loading conditions, and
neuroendocrine activation as pathophysiological
mechanisms for progression of heart failure,10 11
and pharmacological therapy has been targeted against these
mechanisms.12 13 14 However, the fundamental shift
in the etiology of heart failure often is underemphasized. The most
common cause of chronic heart failure is no longer hypertension or
valvular heart disease, as it was in past decades, but rather
coronary artery disease (CAD).15 In 13
multicenter heart failure treatment trials reported in the New
England Journal of Medicine over the past 10
years,16 17 18 19 20 21 22 23 24 25 26 27 28 involving >20 000 patients, CAD
was the underlying etiology of heart failure in nearly 70% of the
patients (Fig 1
). This probably is an underestimation of the true
. . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Alsheikh-Ali, M. H. Al-Mallah, W. Al-Mahmeed, N. Albustani, J. Al Suwaidi, K. Sulaiman, M. Zubaid, and for the Gulf RACE Investigators
Heart failure in patients hospitalized with acute coronary syndromes: observations from the Gulf Registry of Acute Coronary Events (Gulf RACE)
Eur J Heart Fail,
December 1, 2009;
11(12):
1135 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, H. Okada, G. Takemura, K.-i. Kosai, H. Kanamori, M. Esaki, T. Takahashi, K. Goto, A. Tsujimoto, R. Maruyama, et al.
Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction
Am J Physiol Heart Circ Physiol,
October 1, 2009;
297(4):
H1504 - H1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ding, L. Dong, X. Chen, L. Zhang, X. Xu, A. Ferro, and B. Xu
Increased Expression of Integrin-Linked Kinase Attenuates Left Ventricular Remodeling and Improves Cardiac Function After Myocardial Infarction
Circulation,
September 1, 2009;
120(9):
764 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Klapholz
{beta}-Blocker Use for the Stages of Heart Failure
Mayo Clin. Proc.,
August 1, 2009;
84(8):
718 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Rizzello, D Poldermans, E Biagini, A F L Schinkel, E Boersma, A Boccanelli, T Marwick, J R T C Roelandt, and J J Bax
Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction
Heart,
August 1, 2009;
95(15):
1273 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Djousse, J. A. Driver, and J. M. Gaziano
Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure
JAMA,
July 22, 2009;
302(4):
394 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Palaniyandi, L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen
Protein kinase C in heart failure: a therapeutic target?
Cardiovasc Res,
May 1, 2009;
82(2):
229 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
e1 - e90.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation,
April 14, 2009;
119(14):
e391 - e479.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hamamoto, J. H. Gorman III, L. P. Ryan, R. Hinmon, T. P. Martens, M. D. Schuster, T. Plappert, M. Kiupel, M. G. St. John-Sutton, S. Itescu, et al.
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.
Ann. Thorac. Surg.,
March 1, 2009;
87(3):
794 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Pilla, J. H. Gorman III, and R. C. Gorman
Theoretic impact of infarct compliance on left ventricular function.
Ann. Thorac. Surg.,
March 1, 2009;
87(3):
803 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. P. Ryan, K. Matsuzaki, M. Noma, B. M. Jackson, T. J. Eperjesi, T. J. Plappert, M. G. St. John-Sutton, J. H. Gorman III, and R. C. Gorman
Dermal Filler Injection: A Novel Approach for Limiting Infarct Expansion
Ann. Thorac. Surg.,
January 1, 2009;
87(1):
148 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Velagaleti, M. J. Pencina, J. M. Murabito, T. J. Wang, N. I. Parikh, R. B. D'Agostino, D. Levy, W. B. Kannel, and R. S. Vasan
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction
Circulation,
November 11, 2008;
118(20):
2057 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, J. J. Bax, M. M. Henneman, M. J. Boogers, and E. V. Garcia
Is nuclear imaging a viable alternative technique to assess dyssynchrony?
Europace,
November 1, 2008;
10(suppl_3):
iii101 - iii105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-B. le Polain de Waroux, A.-C. Pouleur, C. Goffinet, A. Pasquet, J.-L. Vanoverschelde, and B. L. Gerber
Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging
Eur. Heart J.,
October 2, 2008;
29(20):
2544 - 2551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ghostine, C. Caussin, M. Habis, Y. Habib, C. Clement, A. Sigal-Cinqualbre, C.-Y. Angel, B. Lancelin, A. Capderou, and J.-F. Paul
Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography
Eur. Heart J.,
September 1, 2008;
29(17):
2133 - 2140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Prisant, K. L. Thomas, E. F. Lewis, Z. Huang, G. S. Francis, W. D. Weaver, M. A. Pfeffer, J. J.V. McMurray, R. M. Califf, and E. J. Velazquez
Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both
J. Am. Coll. Cardiol.,
May 13, 2008;
51(19):
1865 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Albert and C. Lewis
Recognizing and Managing Asymptomatic Left Ventricular Dysfunction: After Myocardial Infarction
Crit. Care Nurse,
April 1, 2008;
28(2):
20 - 37.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aghasadeghi and A. Aslani
Differentiation of Ischemic and Dilated Cardiomyopathy on Electrocardiograms
Asian Cardiovasc Thorac Ann,
April 1, 2008;
16(2):
103 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. T. Cung, E. Bonnefoy, D. Angoulvant, J.-F. Aupetit, et al.
Long-Term Benefit of Postconditioning
Circulation,
February 26, 2008;
117(8):
1037 - 1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Blom, J. J. Pilla, J. Arkles, L. Dougherty, L. P. Ryan, J. H. Gorman III, M. A. Acker, and R. C. Gorman
Ventricular Restraint Prevents Infarct Expansion and Improves Borderzone Function After Myocardial Infarction: A Study Using Magnetic Resonance Imaging, Three-Dimensional Surface Modeling, and Myocardial Tagging
Ann. Thorac. Surg.,
December 1, 2007;
84(6):
2004 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tongers and D. W. Losordo
Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells
J. Am. Soc. Nephrol.,
November 1, 2007;
18(11):
2843 - 2852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Najafi, A. J. Dobson, M. Hobbs, and K. Jamrozik
Temporal trends in the frequency and longer-term outcome of heart failure complicating myocardial infarction
Eur J Heart Fail,
September 1, 2007;
9(9):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Duckelmann, F. Mittermayer, D. G. Haider, J. Altenberger, J. Eichinger, and M. Wolzt
Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure
Arterioscler Thromb Vasc Biol,
September 1, 2007;
27(9):
2037 - 2042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gomez, H. Thibault, A. Gharib, J.-M. Dumont, G. Vuagniaux, P. Scalfaro, G. Derumeaux, and M. Ovize
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1654 - H1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Langer, F. Rodriguez, A. Cheng, S. Ortiz, K. B. Harrington, M. K. Zasio, G. T. Daughters, J. C. Criscione, N. B. Ingels, and D. C. Miller
Alterations in Lateral Left Ventricular Wall Transmural Strains During Acute Circumflex and Anterior Descending Coronary Occlusion
Ann. Thorac. Surg.,
July 1, 2007;
84(1):
51 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F.L. Schinkel, D. Poldermans, A. Elhendy, and J. J. Bax
Assessment of Myocardial Viability in Patients with Heart Failure
J. Nucl. Med.,
July 1, 2007;
48(7):
1135 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fedoruk, C. G. Tribble, J. A. Kern, B. B. Peeler, and I. L. Kron
Predicting Operative Mortality After Surgery for Ischemic Cardiomyopathy
Ann. Thorac. Surg.,
June 1, 2007;
83(6):
2029 - 2035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A.C. Lima and J. Hare
Visualizing the Coronaries in Patients Presenting With Heart Failure of Unknown Etiology
J. Am. Coll. Cardiol.,
May 22, 2007;
49(20):
2051 - 2052.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Ray, C. M. Norris, J. A. Udell, R. T. Tsuyuki, F. A. McAlister, M. L. Knudtson, and W. A. Ghali
Lipid-Lowering Therapy and Outcomes in Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2007;
12(1):
27 - 35.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Aronson, N. Goldsher, R. Zukermann, M. Kapeliovich, J. Lessick, D. Mutlak, S. Dabbah, W. Markiewicz, R. Beyar, H. Hammerman, et al.
Ischemic Mitral Regurgitation and Risk of Heart Failure After Myocardial Infarction
Arch Intern Med,
November 27, 2006;
166(21):
2362 - 2368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Adams, L. M. Fedoruk, C. A. Tache-Leon, B. B. Peeler, J. A. Kern, C. G. Tribble, J. D. Bergin, and I. L. Kron
Does Preoperative Ejection Fraction Predict Operative Mortality With Left Ventricular Restoration?
Ann. Thorac. Surg.,
November 1, 2006;
82(5):
1715 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Biagini, M. Valgimigli, P. C. Smits, D. Poldermans, A. F.L. Schinkel, V. Rizzello, E. E.M. Onderwater-, M. Bountioukos, and P. W. Serruys
Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure
Eur J Heart Fail,
October 1, 2006;
8(6):
641 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al.
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
Circulation,
September 12, 2006;
114(11):
1202 - 1213.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Tenhunen, Y. Soini, M. Ilves, J. Rysa, J. Tuukkanen, R. Serpi, H. Pennanen, H. Ruskoaho, and H. Leskinen
p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms
FASEB J,
September 1, 2006;
20(11):
1907 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Goldberg and M. Jessup
Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction
Circulation,
June 20, 2006;
113(24):
2851 - 2860.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Di Mauro, G. Di Giammarco, G. Vitolla, M. Contini, A. L. Iaco, A. Bivona, L. Weltert, and A. M. Calafiore
Impact of No-to-Moderate Mitral Regurgitation on Late Results After Isolated Coronary Artery Bypass Grafting in Patients With Ischemic Cardiomyopathy
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
2128 - 2134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Berry, A. J. Engler, Y. J. Woo, T. J. Pirolli, L. T. Bish, V. Jayasankar, K. J. Morine, T. J. Gardner, D. E. Discher, and H. L. Sweeney
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance
Am J Physiol Heart Circ Physiol,
June 1, 2006;
290(6):
H2196 - H2203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J.L. Murray, S. C. Kulkarni, and M. Ezzati
Understanding the Coronary Heart Disease Versus Total Cardiovascular Mortality Paradox: A Method to Enhance the Comparability of Cardiovascular Death Statistics in the United States
Circulation,
May 2, 2006;
113(17):
2071 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rizzello, D. Poldermans, E. Biagini, A. F.L. Schinkel, E. Boersma, A. Elhendy, F. B. Sozzi, A. Maat, J. R.T.C. Roelandt, and J. J. Bax
Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: Role of myocardial viability
Eur J Heart Fail,
May 1, 2006;
8(3):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Gavira, J. Herreros, A. Perez, M. J. Garcia-Velloso, J. Barba, F. Martin-Herrero, C. Canizo, A. Martin-Arnau, J. M. Marti-Climent, M. Hernandez, et al.
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up
J. Thorac. Cardiovasc. Surg.,
April 1, 2006;
131(4):
799 - 804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ferrazzi, M. L.S. Matteucci, M. Merlo, A. Iacovoni, G. Rescigno, M. Bottai, P. Parrella, L. Lorini, M. Senni, and A. Gavazzi
Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: The relevance of the left ventricular equator as a prognostic factor
J. Thorac. Cardiovasc. Surg.,
February 1, 2006;
131(2):
357 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Rizzello, D Poldermans, A F L Schinkel, E Biagini, E Boersma, A Elhendy, F B Sozzi, A Maat, F Crea, J R T C Roelandt, et al.
Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation
Heart,
February 1, 2006;
92(2):
239 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Jackson, L. M. Parish, J. H. Gorman III, Y. Enomoto, H. Sakamoto, T. Plappert, M. G. St. John Sutton, I. Salgo, and R. C. Gorman
Borderzone Geometry After Acute Myocardial Infarction: A Three-Dimensional Contrast Enhanced Echocardiographic Study
Ann. Thorac. Surg.,
December 1, 2005;
80(6):
2250 - 2255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Pilla, A. S. Blom, J. H. Gorman III, D. J. Brockman, J. Affuso, L. M. Parish, H. Sakamoto, B. M. Jackson, M. A. Acker, and R. C. Gorman
Early Postinfarction Ventricular Restraint Improves Borderzone Wall Thickening Dynamics During Remodeling
Ann. Thorac. Surg.,
December 1, 2005;
80(6):
2257 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Chekanov, A. Dumcius, and P. Karakozov
Adaptive Cardiac Binding: A New Method for Treatment of Dilated Cardiomyopathy
Asian Cardiovasc Thorac Ann,
December 1, 2005;
13(4):
351 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Robinson, J. Li, M. Mathison, A. Redkar, J. Cui, N. A.F. Chronos, R. G. Matheny, and S. F. Badylak
Extracellular Matrix Scaffold for Cardiac Repair
Circulation,
August 30, 2005;
112(9_suppl):
I-135 - I-143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Geidel, M. Lass, C. Schneider, G. Groth, S. Boczor, K.-H. Kuck, and J. Ostermeyer
Downsizing of the mitral valve and coronary revascularization in severe ischemic mitral regurgitation results in reverse left ventricular and left atrial remodeling
Eur. J. Cardiothorac. Surg.,
June 1, 2005;
27(6):
1011 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G I W Galasko, R Senior, and A Lahiri
Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: the Harrow heart failure watch
Heart,
May 1, 2005;
91(5):
595 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Soriano, F. Ridocci, J. Estornell, J. Jimenez, V. Martinez, and J. A. De Velasco
Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
743 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Enomoto, J. H. Gorman III, S. L. Moainie, B. M. Jackson, L. M. Parish, T. Plappert, A. Zeeshan, M. G. St. John-Sutton, and R. C. Gorman
Early Ventricular Restraint After Myocardial Infarction: Extent of the Wrap Determines the Outcome of Remodeling
Ann. Thorac. Surg.,
March 1, 2005;
79(3):
881 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. DeRose Jr, I. K. Toumpoulis, S. K. Balaram, J. P. Ioannidis, S. Belsley, R. C. Ashton Jr, D. G. Swistel, and C. E. Anagnostopoulos
Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction
J. Thorac. Cardiovasc. Surg.,
February 1, 2005;
129(2):
314 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Klauss, P Erdin, J Rieber, M Leibig, H-U Stempfle, A Konig, M Baylacher, K Theisen, M C Haufe, G Sroczynski, et al.
Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis
Heart,
February 1, 2005;
91(2):
203 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Heineke, H. Ruetten, C. Willenbockel, S. C. Gross, M. Naguib, A. Schaefer, T. Kempf, D. Hilfiker-Kleiner, P. Caroni, T. Kraft, et al.
Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc
PNAS,
February 1, 2005;
102(5):
1655 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Ray, Y. Gong, K. Sykora, and J. V. Tu
Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
Arch Intern Med,
January 10, 2005;
165(1):
62 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F L Schinkel, J. J Bax, and D. Poldermans
Clinical assessment of myocardial hibernation
Heart,
January 1, 2005;
91(1):
111 - 117.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rizzello, D. Poldermans, E. Boersma, E. Biagini, A. F.L. Schinkel, B. Krenning, A. Elhendy, E. C. Vourvouri, F. B. Sozzi, A. Maat, et al.
Opposite Patterns of Left Ventricular Remodeling After Coronary Revascularization in Patients With Ischemic Cardiomyopathy: Role of Myocardial Viability
Circulation,
October 19, 2004;
110(16):
2383 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Athanasuleas, G. D. Buckberg, A. W.H. Stanley, W. Siler, V. Dor, M. Di Donato, L. Menicanti, S. Almeida de Oliveira, F. Beyersdorf, I. L. Kron, et al.
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1439 - 1445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bax, J. Braun, S. T. Somer, R. Klautz, E. R. Holman, M. I.M. Versteegh, E. Boersma, M. J. Schalij, E. E. van der Wall, and R. A. Dion
Restrictive Annuloplasty and Coronary Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left Ventricular Remodeling
Circulation,
September 14, 2004;
110(11_suppl_1):
II-103 - II-108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Berry, T. J. Pirolli, V. Jayasankar, J. Burdick, K. J. Morine, T. J. Gardner, and Y. J. Woo
Apelin Has In Vivo Inotropic Effects on Normal and Failing Hearts
Circulation,
September 14, 2004;
110(11_suppl_1):
II-187 - II-193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Bax, E E van der Wall, and M Harbinson
Radionuclide techniques for the assessment of myocardial viability and hibernation
Heart,
August 1, 2004;
90(suppl_5):
v26 - v33.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Roger, S. A. Weston, M. M. Redfield, J. P. Hellermann-Homan, J. Killian, B. P. Yawn, and S. J. Jacobsen
Trends in Heart Failure Incidence and Survival in a Community-Based Population
JAMA,
July 21, 2004;
292(3):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schenk, P. M. McCarthy, R. C. Starling, K. J. Hoercher, M. D. Hail, Y. Ootaki, G. S. Francis, K. Doi, J. B. Young, and K. Fukamachi
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy
J. Thorac. Cardiovasc. Surg.,
July 1, 2004;
128(1):
38 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Cha, M. M. Redfield, W.-K. Shen, and B. J. Gersh
Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle
Circulation,
June 15, 2004;
109(23):
2839 - 2843.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pedersen, I. Raymond, L. H. Madsen, J. Mehlsen, D. Atar, and P. Hildebrandt
Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function
Eur J Heart Fail,
June 1, 2004;
6(4):
439 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, S. N. Hunyor, L. Jiang, O. Kawaguchi, K. Shirota, Y. Ikeda, T. Yuasa, G. Gallagher, B. Zeng, and X. Zheng
Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses
Am J Physiol Heart Circ Physiol,
June 1, 2004;
286(6):
H2141 - H2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Lindley, M. F. Doobay, R. V. Sharma, and R. L. Davisson
Superoxide Is Involved in the Central Nervous System Activation and Sympathoexcitation of Myocardial Infarction-Induced Heart Failure
Circ. Res.,
February 20, 2004;
94(3):
402 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. van Rooij, P. A. Doevendans, H. J.G.M. Crijns, S. Heeneman, D. J. Lips, M. van Bilsen, R. S. Williams, E. N. Olson, R. Bassel-Duby, B. A. Rothermel, et al.
MCIP1 Overexpression Suppresses Left Ventricular Remodeling and Sustains Cardiac Function After Myocardial Infarction
Circ. Res.,
February 20, 2004;
94
(3):
e18 - e26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Steg, O. H. Dabbous, L. J. Feldman, A. Cohen-Solal, M.-C. Aumont, J. Lopez-Sendon, A. Budaj, R. J. Goldberg, W. Klein, F. A. Anderson Jr, et al.
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE)
Circulation,
February 3, 2004;
109(4):
494 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. L. Schinkel, D. Poldermans, V. Rizzello, J.-L. J. Vanoverschelde, A. Elhendy, E. Boersma, J. R.T.C. Roelandt, and J. J. Bax
Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
J. Thorac. Cardiovasc. Surg.,
February 1, 2004;
127(2):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Raymond, F Pedersen, F Steensgaard-Hansen, A Green, M Busch-Sorensen, C Tuxen, J Appel, J Jacobsen, D Atar, and P Hildebrandt
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
Heart,
December 1, 2003;
89(12):
1422 - 1429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. De Smet, M. F. Menadue, J. R. Oliver, and P. A. Phillips
Increased thirst and vasopressin secretion after myocardial infarction in rats
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2003;
285(5):
R1203 - R1211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gattenlohner, C. Waller, G. Ertl, B.-D. Bultmann, H.-K. Muller-Hermelink, and A. Marx
NCAM(CD56) and RUNX1(AML1) Are Up-Regulated in Human Ischemic Cardiomyopathy and a Rat Model of Chronic Cardiac Ischemia
Am. J. Pathol.,
September 1, 2003;
163(3):
1081 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Hellermann, T. Y. Goraya, S. J. Jacobsen, S. A. Weston, G. S. Reeder, B. J. Gersh, M. M. Redfield, R. J. Rodeheffer, B. P. Yawn, and V. L. Roger
Incidence of Heart Failure after Myocardial Infarction: Is It Changing over Time?
Am. J. Epidemiol.,
June 15, 2003;
157(12):
1101 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade, W. S. Colucci, and K. Swedberg
{beta}-Blockers in Chronic Heart Failure
Circulation,
April 1, 2003;
107(12):
1570 - 1575.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Felker, R. L. Benza, A. B. Chandler, J. D. Leimberger, M. S. Cuffe, R. M. Califf, M. Gheorghiade, C. M. O'Connor, and OPTIME-CHF Investigators
Heart failure etiology and response tomilrinone in decompensated heart failure: Results from the OPTIME-CHF study
J. Am. Coll. Cardiol.,
March 19, 2003;
41(6):
997 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.O Bonetti, L.O Lerman, C Napoli, and A Lerman
Statin effects beyond lipid lowering--are they clinically relevant?
Eur. Heart J.,
February 1, 2003;
24(3):
225 - 248.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L.R. Kam, R. Valkema, D. Poldermans, J. J. Bax, A. E.M. Reijs, R. Rambaldi, E. Boersma, T. Rietveld, J. R.T.C. Roelandt, and E. P. Krenning
Feasibility and Image Quality of Dual-Isotope SPECT Using 18F-FDG and 99mTc-Tetrofosmin After Acipimox Administration
J. Nucl. Med.,
February 1, 2003;
44(2):
140 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Jackson, J. H. Gorman III, I. S. Salgo, S. L. Moainie, T. Plappert, M. St. John-Sutton, L. H. Edmunds Jr., and R. C. Gorman
Border zone geometry increases wall stress after myocardial infarction: contrast echocardiographic assessment
Am J Physiol Heart Circ Physiol,
February 1, 2003;
284(2):
H475 - H479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Duncan, D. P. Francis, M. Y. Henein, and D. G. Gibson
Limitation of cardiac output by total isovolumic time during pharmacologic stress in patients with dilated cardiomyopathy: Activation-mediated effects of leftbundle branch block and coronary artery disease
J. Am. Coll. Cardiol.,
January 1, 2003;
41(1):
121 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev,
January 1, 2003;
83(1):
59 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Moainie, J. H. Gorman III, T. S. Guy, F. W. Bowen III, B. M. Jackson, T. Plappert, N. Narula, M. G. St. John-Sutton, J. Narula, L. H. Edmunds Jr, et al.
An ovine model of postinfarction dilated cardiomyopathy
Ann. Thorac. Surg.,
September 1, 2002;
74(3):
753 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Kjeldsen, A Norgaard, and M Gheorghiade
Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure
Cardiovasc Res,
September 1, 2002;
55(4):
710 - 713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Moainie, T. S. Guy, J. H. Gorman III, T. Plappert, B. M. Jackson, M. G. St. John-Sutton, L. H. Edmunds Jr, and R. C. Gorman
Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after postero-lateral infarction
Ann. Thorac. Surg.,
August 1, 2002;
74(2):
444 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A F L Schinkel, J J Bax, F B Sozzi, E Boersma, R Valkema, A Elhendy, J R T C Roelandt, and D Poldermans
Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction
Heart,
August 1, 2002;
88(2):
125 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade and S. Goldstein
{beta}-Blockers in the Post-Myocardial Infarction Patient
Circulation,
July 23, 2002;
106(4):
394 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tenenbaum, E. Z. Fisman, and M. Motro
Toward a redefinition of ischemic cardiomyopathy: is it an indivisible entity?
J. Am. Coll. Cardiol.,
July 3, 2002;
40(1):
205 - 206.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bax, J. Maddahi, D. Poldermans, A. Elhendy, J. H. Cornel, E. Boersma, J. R.T.C. Roelandt, and P. M. Fioretti
Sequential 201Tl Imaging and Dobutamine Echocardiography to Enhance Accuracy of Predicting Improved Left Ventricular Ejection Fraction After Revascularization
J. Nucl. Med.,
June 1, 2002;
43(6):
795 - 802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow, W. E. Mitch, R. W. Nesto, P. T. O'Gara, R. C. Becker, L. T. Clark, S. Hunt, I. Jialal, S. E. Lipshultz, and E. Loh
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications
Circulation,
May 7, 2002;
105
(18):
e159 - e164.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow
Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction
J. Am. Coll. Cardiol.,
April 3, 2002;
39(7):
1159 - 1162.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Cuffe, R. M. Califf, K. F. Adams Jr, R. Benza, R. Bourge, W. S. Colucci, B. M. Massie, C. M. O'Connor, I. Pina, R. Quigg, et al.
Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure: A Randomized Controlled Trial
JAMA,
March 27, 2002;
287(12):
1541 - 1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Gould, G. E. Taffet, L. H. Michael, R. M. Christie, D. L. Konkol, J. S. Pocius, J. P. Zachariah, D. F. Chaupin, S. L. Daniel, G. E. Sandusky Jr., et al.
Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure
Am J Physiol Heart Circ Physiol,
February 1, 2002;
282(2):
H615 - H621.
[Abstract]
[Full Text]
[PDF]
|
 |
|